| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXHL2200976 | 复方盐酸替利定缓释片 | naloxone;TILIDINE | Tablet, extended release | Chemical Drugs(2.2) | New Drug Application | 2022-12-30 | HeBei Aoxing Group Pharmaceutical Co Ltd | view |